High sensitivity [lbpr]
C-reactive protein [aapp, imft]
complements [aapp, imft]
Plasma [bdsu]
Epstein [dsyn]
Virus [virs]
Deoxyribonucleic Acid [bacs, nnon]
Nasopharyngeal carcinoma [neop]
Large [qnco]
Scale [medd]
retrospective [resa]
Prospective Cohort Study [resa]
Purpose [ftcn]
To [qlco]
Evaluate [ftcn]
effects [qlco]
Combine [mnob]
Assessment [hlca]
Circulating [ftcn]
High sensitivity [lbpr]
C-reactive protein [aapp, imft]
Epstein-Barr virus DNA [bacs, nnon]
Pre-Therapy [tmco]
Nasopharyngeal carcinoma [neop]
Patients [podg]
Methods [inpr]
Three [qnco]
Independent [idcn]
cohorts [popg]
Nasopharyngeal carcinoma [neop]
Patients [podg]
Training [edac]
Set [menp]
N NOS [aapp, imft]
Internal [spco]
Validation [resa]
Set [menp]
N NOS [aapp, imft]
prospective [resa]
Validation [resa]
Set [menp]
N NOS [aapp, imft]
Study [mnob]
Determinant [ftcn]
Disease-Free Survival [qnco]
Distant metastasis [clas]
free [ftcn]
Survival [acty]
Overall [inpr]
Survival [acty]
Assessed [acty]
Multivariate Analysis [qnco]
Hazard Ratio [qnco]
Survival [acty]
Probabilities [qnco]
Group [idcn]
Clinical stage [tmco]
Epstein-Barr virus DNA [bacs, nnon]
Load [idcn]
low [qlco]
High [qlco]
Alone [qnco]
High sensitivity [lbpr]
C-reactive protein level [lbpr]
low [qlco]
High [qlco]
Compared [acty]
Result [ftcn]
Elevated [qlco]
High sensitivity [lbpr]
C-reactive protein [aapp, imft]
Epstein-Barr virus DNA [bacs, nnon]
Levels [qlco]
Correlated [qlco]
Poor [grpa]
Disease-Free Survival [qnco]
Distant [spco]
Survival [acty]
Overall [inpr]
Survival [acty]
Training [edac]
Validation [resa]
Set [menp]
Associations [menp]
Similar [qlco]
Exclude [ftcn]
Patients [podg]
Cardiovascular disease [dsyn]
Diabetes [dsyn]
Hepatitis B, Chronic [dsyn]
Patients [podg]
Advanced [qlco]
Stage [tmco]
Disease [dsyn]
High [qlco]
Epstein-Barr virus DNA [bacs, nnon]
Levels [qlco]
High sensitivity [lbpr]
C-reactive protein level [lbpr]
Poor [grpa]
Risk [qlco]
Group [idcn]
participants [popg]
High [qlco]
Epstein-Barr virus DNA [bacs, nnon]
low [qlco]
High sensitivity [lbpr]
C-reactive protein level [lbpr]
High sensitivity [lbpr]
C-reactive protein [aapp, imft]
low [qlco]
Epstein-Barr virus DNA [bacs, nnon]
Values [qlco]
Poor [grpa]
Survival [acty]
Compared [acty]
Bottom [spco]
Values [qlco]
Biomarkers [clna]
findings [ftcn]
Improvement [cnce]
prognostic [inpr]
Ability [orga]
Conventional [qlco]
Advanced [qlco]
Nasopharyngeal carcinoma [neop]
Staging [ftcn]
Conclusion [idcn]
baseline [bodm]
Plasma [bdsu]
Epstein-Barr virus DNA [bacs, nnon]
Serum C reactive protein level [lbpr]
High sensitivity [lbpr]
Correlated [qlco]
Survival [acty]
Nasopharyngeal carcinoma [neop]
Patients [podg]
Combined [qlco]
Interpretation [inpr]
Epstein-Barr virus DNA [bacs, nnon]
High sensitivity [lbpr]
C-reactive protein level [lbpr]
LED [mnob]
Risks [qlco]
Subset [clas]
Improved [qlco]
Risk [qlco]
Discrimination [menp]
Patients [podg]
Advanced [qlco]
Stage [tmco]
Disease [dsyn]
[c] [qnco]
